For instance, in an in vivo breast cancer mouse model, it was demonstrated that CCND1 silencing enhanced glycolysis and mitochondrial activity, whereas CCND1 overexpression in the mammary glands inhibited not only glycolysis, but also fatty acid synthesis and the expression of several key mitochondrial genes [177]. This evidence concerns the gene CCND1 and breast cancer.